Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Kit for detecting free breast cancer cell marker in blood

A technology of breast cancer cells and markers, applied in the field of detection kits for free breast cancer cells, can solve the problems of inaccurate judgment, non-specificity of tumor cells, and high detection cost

Active Publication Date: 2013-10-16
牛刚 +2
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Second, the chemical and physical means adopted have no therapeutic specificity for tumor cells
But this detection method is very inaccurate
We know that the increase in the content of tumor markers may be due to the secretion of tumor cells, or other factors such as stress responses may cause the increase in the protein content of the marker, so even if the increase in the content of tumor markers is detected, it cannot be accurately judged whether the tumor markers are in the blood. Tumor cells or cancer stem cells really exist
Faced with these problems, the usual practice of those skilled in the art is to combine multiple tumor markers to increase the accuracy of detection, but the cost of detection is very high, and it is difficult for ordinary patients to accept
In addition, even if combined with detection, it cannot be concluded that the detection must be accurate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for detecting free breast cancer cell marker in blood
  • Kit for detecting free breast cancer cell marker in blood
  • Kit for detecting free breast cancer cell marker in blood

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] The preparation of embodiment 1 magnetic beads

[0039] Preparation of antibody immunomagnetic beads: the antibodies used were anti-BerEP4 monoclonal antibody, anti-cytokeratin monoclonal antibody and anti-HER2 monoclonal antibody. In the present invention, the above three kinds of antibodies are labeled separately and then mixed for use. It is also possible to select one or two antibodies for separate labeling and mixed use.

[0040] Methods: Dynabeads Antibody Coupling Kit produced by Invitrogen was used. The labeling method was carried out in strict accordance with the manufacturer's instructions.

Embodiment 2

[0041] The separation of embodiment 2 breast cancer cells

[0042] 1. Sample collection:

[0043] Collect 5-7.5ml of peripheral blood from breast cancer patients, anticoagulate with EDTA, and use it within 4 hours (or use it within 48 hours after storage at 4 degrees).

[0044] 2. Select magnetic beads:

[0045] 2.1 Processing of magnetic beads:

[0046] Mix the magnetic beads evenly, use a pipette to blow gently, and do not use a vortexer;

[0047] Use PBS buffer solution to wash, and do not touch the microspheres when washing;

[0048] Draw more magnetic beads than the required sample volume and add them to a 1.5ml centrifuge tube;

[0049] Put it on the magnet for 1 minute, discard the supernatant;

[0050] Wash 3 times with 1ml PBS to remove preservatives;

[0051] Remove the supernatant;

[0052] · Aspirate 100ul microspheres containing PBS with the same volume as the original one.

[0053] 2.2 Selection of tumor cells

[0054] Put 5ml of peripheral blood into a ...

Embodiment 3

[0073] Example 3 Detection of Breast Cancer Cell Tumor Markers

[0074] 3.1 Kit preparation

[0075] Keep the test tube at room temperature;

[0076] Put the RNase-free water in the kit at room temperature;

[0077] Place the centrifuge tube above the tube containing the supernatant on ice;

[0078] · Prepare magnetic beads.

[0079] 3.2 Preparation of oligonucleotides

[0080] Take an appropriate amount of magnetic beads with oligonucleotide Oligo(dT) (it is recommended not to mix with a suspension apparatus, but to suspend by hand);

[0081] · Transfer to a 1.5ml tube;

[0082] • Wash twice with lysis / binding buffer.

[0083] 3.3 Binding mRNA to magnetic beads

[0084] Add 20 μl of magnetic beads to each cell lysis sample;

[0085] • Incubate for 10 minutes.

[0086] 3.4 Purification of mRNA

[0087] Wash twice with buffer solution;

[0088] Wash the magnetic beads twice with buffer;

[0089] Wash again with 100 μl Tris-HCl buffer;

[0090] • Suspend the magneti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a kit for detecting a breast cancer marker. The kit comprises the following components: magnetic bead processing solution, a magnetic bead with a breast cancer antibody, 4.0 to 5.0mu l of 10X buffer solution, 4.0 to 5.0mu l of deoxynucleoside triphosphates (dNTPs), 2.0 to 3.0mu l of reverse transcriptase, 0.4 to 0.6mu l of 40u / mu l ribonucleic acid (RNA) enzyme inhibitor, 20.0 to 30.0mu l of 10X hot start polymerase chain reaction (PCR) mixed solution, 10.0 to 15.0mu l of ddH2O and 3.0 to 5.0mu l of breast cancer marker primer. Compared with the prior art, the kit can more accurately detect the breast cancer marker in peripheral blood, and has great guiding significance for selecting breast cancer prognosis schemes and treatment schemes.

Description

technical field [0001] The present invention relates to a detection kit and composite detection technology, in particular to a high-accuracy detection technology and kit for detecting breast cancer cells (malignant tumor cells) from the circulating blood of breast cancer patients, especially capable of separating A detection kit for extracting and identifying free breast cancer cells remaining in the patient's blood after radiotherapy and chemotherapy. Background technique [0002] As the killer of malignant tumors, breast cancer has an obvious rising trend. The high incidence of breast cancer is increasingly harmful to human beings, especially women. For the early diagnosis and screening of breast cancer and the prognosis of treatment effect, as well as the evaluation and prediction of the curative effect after chemotherapy and radiotherapy, it is of great practical significance to reduce the mortality rate of breast cancer and increase the 5-year survival rate. [0003] ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68
Inventor 牛刚谭焕然李玉琪
Owner 牛刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com